From: Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases
CLQ arm
Controlarm
p
n=22
%
n=20
Complete
1
4.5
2
10
.915
Partial
11
50
9
47.3
.867
Stable disease
40.9
.678
Progressive disease
0
.347
Objective response
12
54
55
.902